The states with the highest rates of HIV diagnoses in 2021 included Georgia, Louisiana, and Florida. However, the states with the highest number of people with HIV were California, Texas, and Florida. In California, there were around 4,399 people diagnosed with HIV. HIV/AIDS diagnoses The number of diagnoses of HIV/AIDS in the United States has continued to decrease in recent years. In 2021, there were an estimated 35,769 HIV diagnoses in the U.S. down from 38,433 diagnoses in the year 2017. In total, since the beginning of the epidemic in 1981 there have been around 1.25 million diagnoses in the United States. Deaths from HIV Similarly, the death rate from HIV has also decreased significantly over the past few decades. In 2019, there were only 1.4 deaths from HIV per 100,000 population, the lowest rate since the epidemic began. However, the death rate varies greatly depending on race or ethnicity, with the death rate from HIV for African Americans reaching 19.1 per 100,000 population in 2020.

This data set includes tables on persons living with HIV/AIDS, newly diagnosed HIV cases and all cause deaths in HIV/AIDS cases by gender, age, race/ethnicity and transmission category.

In all tables, cases are reported as of December 31 of the given year, as reported by January 9, 2019, to allow a minimum of 12 months reporting delay.

Gender is determined by both current gender and sex at birth variables; transgender values are assigned when current gender is identified as "Transgender" or when a discrepancy is identified between a person's sex at birth and their current gender (e.g., cases where sex at birth is "Male" and current gender is "Female" will become Transgender: Male to Female.) Prior to 2003, Asian and Native Hawaiian/Pacific Islanders were classified as one combined group. In order to present these race/ethnicities separately, living cases recorded under this combined classification were split and redistributed according to their expected proportional population representation estimated from post-2003 data.

The Philippines reported about 17,250 HIV cases, an increase of about 2,300 cases from the previous year. The number of reported HIV cases has gradually increased since 2012, aside from a significant dip in 2020. The state of HIV in the Philippines  As the daily average number of people newly diagnosed with HIV increases, the risk it poses threatens the lives of Filipinos. HIV is a sexually transmitted infection that attacks the body’s immune system, with more males being diagnosed than females. In 2022, the majority of people newly diagnosed with HIV were those between the age of 25 and 34 years, followed by those aged 15 and 24. There is still no cure for HIV and without treatment, it could lead to other severe illnesses such as tuberculosis and cancers such as lymphoma and Kaposi’s sarcoma. However, HIV is now a manageable chronic illness that can be treated with proper medication. What are the leading causes of death in the Philippines? In 2023, preliminary figures indicate that ischaemic heart disease led to the deaths of about 124,500 people, making it the leading cause of death in the Philippines. The prevalence of heart diseases in the nation has been closely attributed to the Filipino diet, which was described as having a high fat, high cholesterol, and high sodium content. In addition, acute respiratory infections and hypertension also registered the highest morbidity rate among leading diseases in the country in 2021.

Effect of suicide rates on life expectancy dataset

Abstract
In 2015, approximately 55 million people died worldwide, of which 8 million committed suicide. In the USA, one of the main causes of death is the aforementioned suicide, therefore, this experiment is dealing with the question of how much suicide rates affects the statistics of average life expectancy.
The experiment takes two datasets, one with the number of suicides and life expectancy in the second one and combine data into one dataset. Subsequently, I try to find any patterns and correlations among the variables and perform statistical test using simple regression to confirm my assumptions.

Data

The experiment uses two datasets - WHO Suicide Statistics[1] and WHO Life Expectancy[2], which were firstly appropriately preprocessed. The final merged dataset to the experiment has 13 variables, where country and year are used as index: Country, Year, Suicides number, Life expectancy, Adult Mortality, which is probability of dying between 15 and 60 years per 1000 population, Infant deaths, which is number of Infant Deaths per 1000 population, Alcohol, which is alcohol, recorded per capita (15+) consumption, Under-five deaths, which is number of under-five deaths per 1000 population, HIV/AIDS, which is deaths per 1 000 live births HIV/AIDS, GDP, which is Gross Domestic Product per capita, Population, Income composition of resources, which is Human Development Index in terms of income composition of resources, and Schooling, which is number of years of schooling.

LICENSE

THE EXPERIMENT USES TWO DATASET - WHO SUICIDE STATISTICS AND WHO LIFE EXPECTANCY, WHICH WERE COLLEECTED FROM WHO AND UNITED NATIONS WEBSITE. THEREFORE, ALL DATASETS ARE UNDER THE LICENSE ATTRIBUTION-NONCOMMERCIAL-SHAREALIKE 3.0 IGO (https://creativecommons.org/licenses/by-nc-sa/3.0/igo/).

[1] https://www.kaggle.com/szamil/who-suicide-statistics

[2] https://www.kaggle.com/kumarajarshi/life-expectancy-who

Tuberculosis (TB) and HIV/AIDS are public health concerns in Papua New Guinea (PNG). This study examines TB and HIV/AIDS mortalities and associated sociodemographic factors in PNG. Method: As part of a longitudinal study, verbal autopsy (VA) interviews were conducted using the WHO 2016 VA Instrument to collect data of 926 deaths occurred in the communities within the catchment areas of the Comprehensive Health and Epidemiological Surveillance System from 2018-2020. InterVA-5 cause of deaths analytic tool was used to assign specific causes of death (COD). Multinomial logistic regression analyses were conducted to identify associated sociodemographic factors, estimate odds ratios (OR), 95% confidential intervals and p-values. Result: TB and HIV/AIDS were the leading CODs from infectious diseases, attributed to 9% and 8% of the total deaths, respectively. Young adults (25-34 years) had the highest proportion of deaths from TB (20%) and the risk of dying from TB among this age group was five times more likely than those aged 75+ years (OR: 5.5 [1.4-21.7]). Urban population were 46% less likely to die from this disease compared rural ones (OR: 0.54 [0.3-1.0]). People from middle household wealth quintile were three times more likely to die from TB than those in the richest quintile (OR: 3.0 [1.3-7.4]). Young adults also had the highest proportion of deaths to HIV/AIDS (18%) and were nearly seven times more likely to die from this disease compared with those aged 75+ years (OR: 6.7 [1.7-25.4]). Males were 48% less likely to die from HIV/AIDS than females (OR: 0.52 [0.3-0.9]). The risk of dying from HIV/AIDS in urban population was 54% less likely than their rural counterparts (OR: 0.46 [0.2-0.9]). Conclusion: TB and HIV/AIDS interventions are needed to target high-risk and vulnerable populations to reduce premature mortality from these diseases in PNG.

This table presents a wide variety of historical data in the field of health, lifestyle and health care. Figures on births and mortality, causes of death and the occurrence of certain infectious diseases are available from 1900, other series from later dates. In addition to self-perceived health, the table contains figures on infectious diseases, hospitalisations per diagnosis, life expectancy, lifestyle factors such as smoking, alcohol consumption and obesity, and causes of death. The table also gives information on several aspects of health care, such as the number of practising professionals, the number of available hospital beds, nursing day averages and the expenditures on care. Many subjects are also covered in more detail by data in other tables, although sometimes with a shorter history. Data on notifiable infectious diseases and HIV/AIDS are not included in other tables. Data available from: 1900 Status of the figures: 2024: The available figures are definite. 2023: Most available figures are definite. Figures are provisional for: - occurrence of infectious diseases; - expenditures on health and welfare; - perinatal and infant mortality. 2022: Most available figures are definite. Figures are provisional for: - occurrence of infectious diseases; - diagnoses at hospital admissions; - number of hospital discharges and length of stay; - number of hospital beds; - health professions; - expenditures on health and welfare. 2021: Most available figures are definite. Figures are provisional for: - occurrence of infectious diseases; - expenditures on health and welfare. 2020 and earlier: Most available figures are definite. Due to 'dynamic' registrations, figures for notifiable infectious diseases, HIV, AIDS remain provisional. Changes as of 18 december 2024: - Due to a revision of the statistics Health and welfare expenditure 2021, figures for expenditure on health and welfare have been replaced from 2021 onwards. - Revised figures on the volume index of healthcare costs are not yet available, these figures have been deleted from 2021 onwards. The most recent available figures have been added for: - live born children, deaths; - occurrence of infectious diseases; - number of hospital beds; - expenditures on health and welfare; - perinatal and infant mortality; - healthy life expectancy; - causes of death. When will new figures be published? July 2025.

Objective: To examine if the rankings of state HIV age-standardized death rates (ASDRs) changed if different standard population (SP) was used. Design: A cross-sectional population-based observational study. Setting 36 states in the United States. Participants: People died from 2015 to 2019. Main outcome measures: State HIV ASDR using 4 SPs, namely WHO2000, US2000, US2mor020, and Eur2011–2030. Results: The rankings of 19 states did not change when ASDRs were calculated using US2000 and US2020. Of the 17 states whose rankings changed, the rankings of 9 states calculated using US2000 were higher than those calculated using US2020; in 8 states, the rankings were lower. The states with the greatest changes in rankings between US2000 and US2020 were Kentucky (12th and 9th, respectively) and Massachusetts (8th and 11th, respectively). Conclusions: State ASDRs calculated using the current official SP (US2000) weigh middle-age HIV death rates more heavily than older-age HIV death rates, resulting in lower ASDRs among states with higher older-age HIV death rates. Methods The data were extracted from CDC WONDER.

Nigeria NG: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Male data was reported at 20.900 NA in 2016. This records an increase from the previous number of 20.800 NA for 2015. Nigeria NG: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Male data is updated yearly, averaging 21.000 NA from Dec 2000 (Median) to 2016, with 5 observations. The data reached an all-time high of 22.600 NA in 2000 and a record low of 20.800 NA in 2015. Nigeria NG: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Male data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Nigeria – Table NG.World Bank.WDI: Health Statistics. Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).; ; World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).; Weighted average;

Geographic coverage

The survey was conducted in two local communities in the Free State province, one urban (Welkom) and one rural (Qwaqwa), in which the HIV/AIDS epidemic is particularly rife. Welkom and Qwaqwa are situated in the Lejweleputswa and Thabo Mofutsanyane districts of the Free State province.

Analysis unit

Households

Universe

All memebers of the Household

Kind of data

Sample survey data [ssd]

Sampling procedure

The household impact of HIV/AIDS was assessed by means of a cohort study of households affected by the disease. The survey was conducted in two local communities in the Free State province, one urban (Welkom) and one rural (Qwaqwa), in which the HIV/AIDS epidemic is particularly rife. Welkom and Qwaqwa are situated in the Lejweleputswa and Thabo Mofutsanyane districts of the Free State province.

Affected households were sampled purposively via NGOs and other organizations involved in AIDS counselling and care and at baseline included at least one person known to be HIV-positive or known to have died from AIDS in the past six months. Informed consent was obtained from the infected individual(s) or their caregivers (in the case of minors). In order to explore the socio-economic impact on affected households of repeated occurrences of HIV/AIDS-related morbidity or mortality, a distinction is made between affected households in general and affected households that have experienced morbidity or mortality more frequently. Non-affected households represent households living in close proximity to affected households. These households at baseline did not include persons suffering from tuberculosis or pneumonia. The incidence of morbidity and mortality is considerably higher in affected households.

Affected households were sampled purposively via NGOs and other organizations involved in AIDS counselling and care and at baseline included at least one person known to be HIV-positive or known to have died from AIDS in the past six months. Informed consent was obtained from the infected individual(s) or their caregivers (in the case of minors). In order to explore the socio-economic impact on affected households of repeated occurrences of HIV/AIDS-related morbidity or mortality, a distinction is made between affected households in general and affected households that have experienced morbidity or mortality more frequently. Non-affected households represent households living in close proximity to affected households. These households at baseline did not include persons suffering from tuberculosis or pneumonia. The incidence of morbidity and mortality is considerably higher in affected households.

Mode of data collection

Face-to-face [f2f]

Research instrument

Household Questionnaire

Response rate

During the first wave of interviews a total of 404 interviews were conducted. During the second wave of data collection, interviews were conducted with 385 households, which translates into an attrition rate of 4.7% (19 households). During wave III, a total of 354 households were interviewed, with 31 households not being reinterviewed (7.7% of the original sample). In wave IV, 55 new households wererecruited into the study, with particular emphasis on an effort to recruit child-headed households into the survey insofar as the sample to date did not include any such households. During waves IV, V and VI a total of 3, 13 and 9 households respectively could not be re-interviewed.

The payment of a minimal participation fee (R150 per household per survey visit) to those households interviewed in each wave, following the interview and distributed in the form of food parcels, contributed to ensuring sustainability of the sample over the three-year period. The dataset includes data for 331 households interviewed in each of the six rounds of interviews. In almost 90 percent of cases the reasons for attrition are related to migration, given that this study did not intend to follow those households that move outside of the two immediate study areas, i.e. Welkom and Qwaqwa. In the majority of cases, attrition can be ascribed to the failure to establish the current whereabouts of the particular household during follow-up, while in a third of cases it could be established that the household had moved to another country, another province, or another town in the Free State province. Less than ten percent of households had refused to participate in subsequent waves. The reasons for attrition in the original sample illustrate the manner in which migration and the disintegration of households, which are important effects of the epidemic, can act to erode the sample population.

Users can access data related to international women’s health as well as data on population and families, education, work, power and decision making, violence against women, poverty, and environment. Background World’s Women Reports are prepared by the Statistics Division of the United Nations Department for Economic and Social Affairs (UNDESA). Reports are produced in five year intervals and began in 1990. A major theme of the reports is comparing women’s situation globally to that of men in a variety of fields. Health data is available related to life expectancy, cause of death, chronic disease, HIV/AIDS, prenatal care, maternal morbidity, reproductive health, contraceptive use, induced abortion, mortality of children under 5, and immunization. User functionality Users can download full text or specific chapter versions of the reports in color and black and white. A limited number of graphs are available for download directly from the website. Topics include obesity and underweight children. Data Notes The report and data tables are available for download in PDF format. The next report is scheduled to be released in 2015. The most recent report was released in 2010.

BackgroundGlobal and regional projections of mortality and burden of disease by cause for the years 2000, 2010, and 2030 were published by Murray and Lopez in 1996 as part of the Global Burden of Disease project. These projections, which are based on 1990 data, continue to be widely quoted, although they are substantially outdated; in particular, they substantially underestimated the spread of HIV/AIDS. To address the widespread demand for information on likely future trends in global health, and thereby to support international health policy and priority setting, we have prepared new projections of mortality and burden of disease to 2030 starting from World Health Organization estimates of mortality and burden of disease for 2002. This paper describes the methods, assumptions, input data, and results. Methods and FindingsRelatively simple models were used to project future health trends under three scenarios—baseline, optimistic, and pessimistic—based largely on projections of economic and social development, and using the historically observed relationships of these with cause-specific mortality rates. Data inputs have been updated to take account of the greater availability of death registration data and the latest available projections for HIV/AIDS, income, human capital, tobacco smoking, body mass index, and other inputs. In all three scenarios there is a dramatic shift in the distribution of deaths from younger to older ages and from communicable, maternal, perinatal, and nutritional causes to noncommunicable disease causes. The risk of death for children younger than 5 y is projected to fall by nearly 50% in the baseline scenario between 2002 and 2030. The proportion of deaths due to noncommunicable disease is projected to rise from 59% in 2002 to 69% in 2030. Global HIV/AIDS deaths are projected to rise from 2.8 million in 2002 to 6.5 million in 2030 under the baseline scenario, which assumes coverage with antiretroviral drugs reaches 80% by 2012. Under the optimistic scenario, which also assumes increased prevention activity, HIV/AIDS deaths are projected to drop to 3.7 million in 2030. Total tobacco-attributable deaths are projected to rise from 5.4 million in 2005 to 6.4 million in 2015 and 8.3 million in 2030 under our baseline scenario. Tobacco is projected to kill 50% more people in 2015 than HIV/AIDS, and to be responsible for 10% of all deaths globally. The three leading causes of burden of disease in 2030 are projected to include HIV/AIDS, unipolar depressive disorders, and ischaemic heart disease in the baseline and pessimistic scenarios. Road traffic accidents are the fourth leading cause in the baseline scenario, and the third leading cause ahead of ischaemic heart disease in the optimistic scenario. Under the baseline scenario, HIV/AIDS becomes the leading cause of burden of disease in middle- and low-income countries by 2015. ConclusionsThese projections represent a set of three visions of the future for population health, based on certain explicit assumptions. Despite the wide uncertainty ranges around future projections, they enable us to appreciate better the implications for health and health policy of currently observed trends, and the likely impact of fairly certain future trends, such as the ageing of the population, the continued spread of HIV/AIDS in many regions, and the continuation of the epidemiological transition in developing countries. The results depend strongly on the assumption that future mortality trends in poor countries will have a relationship to economic and social development similar to those that have occurred in the higher-income countries.

India IN: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Female data was reported at 19.800 NA in 2016. This records a decrease from the previous number of 20.000 NA for 2015. India IN: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Female data is updated yearly, averaging 21.200 NA from Dec 2000 (Median) to 2016, with 5 observations. The data reached an all-time high of 23.400 NA in 2000 and a record low of 19.800 NA in 2016. India IN: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Female data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s India – Table IN.World Bank.WDI: Health Statistics. Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).; ; World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).; Weighted average;

Early initiation of antiretroviral therapy (ART) reduces the risk of drug-sensitive HIV transmission but may increase the transmission of drug-resistant HIV. We used a mathematical model to estimate the long-term population-level benefits of ART and determine the scenarios under which earlier ART (treatment at 1 year post-infection, on average) could decrease simultaneously both total and drug-resistant HIV incidence (new infections). We constructed an infection-age-structured mathematical model that tracked the transmission rates over the course of infection and modelled the patients' life expectancy as a function of ART initiation timing. We fitted this model to the annual AIDS incidence and death data directly, and to resistance data and demographic data indirectly among men who have sex with men (MSM) in San Francisco. Using counterfactual scenarios, we assessed the impact on total and drug-resistant HIV incidence of ART initiation timing, frequency of acquired drug resistance, and second-line drug effectiveness (defined as the combination of resistance monitoring, biomedical drug efficacy and adherence). Earlier ART initiation could decrease the number of both total and drug-resistant HIV incidence when second-line drug effectiveness is sufficiently high (greater than 80%), but increase the proportion of new infections that are drug resistant. Thus, resistance may paradoxically appear to be increasing while actually decreasing.

Ivory Coast CI: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Female data was reported at 30.100 NA in 2016. This records a decrease from the previous number of 30.300 NA for 2015. Ivory Coast CI: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Female data is updated yearly, averaging 29.800 NA from Dec 2000 (Median) to 2016, with 5 observations. The data reached an all-time high of 30.300 NA in 2015 and a record low of 27.500 NA in 2000. Ivory Coast CI: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Female data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Ivory Coast – Table CI.World Bank.WDI: Health Statistics. Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).; ; World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).; Weighted average;

Saudi Arabia SA: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data was reported at 16.400 % in 2016. This records a decrease from the previous number of 16.500 % for 2015. Saudi Arabia SA: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data is updated yearly, averaging 17.900 % from Dec 2000 (Median) to 2016, with 5 observations. The data reached an all-time high of 18.900 % in 2000 and a record low of 16.400 % in 2016. Saudi Arabia SA: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Saudi Arabia – Table SA.World Bank: Health Statistics. Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).; ; World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).; Weighted Average;

Title: The impact of COVID-19 on chronic care patients health care utilization and health outcomes in Haiti, Malawi, Mexico and Rwanda Original data source: Electronic Medical Records Date range: March 1st, 2019-Feb 28th, 2021 Geographic region: Non-representative subnational regions of Haiti, Malawi, Mexico, and Rwanda Clinical populations: Diabetes, HIV, and hypertension patients Level of data: Aggregated by country, sex, age category, clinical population, and pre- vs post-COVID-19 period Size of the data: 35 KB Research question/s that use the dataset 1. Has the COVID-19 pandemic changed the risk of poor clinical outcomes among chronic care patients living with HIV, cardiovascular disease and diabetes programs in Haiti, Malawi, Mexico and Rwanda? 2. Among these patients, how has care utilization changed during the COVID-19 pandemic? Useful Links https://icoda-research.org/project/dp-pih-covco/

Data access information: In order to request access to data, please contact Jean Claude Mugunga, jmugunga@pih.org, with a description of your study team, your research questions, and which countr(ies) and clinical program(s) you would like data for. Note that Dr. Mugugna will reach out to representatives from each country you request data from for approval before sharing the data.

BackgroundDespite the effectiveness of antiretroviral therapy in reducing mortality from opportunistic infections among people living with HIV (PLHIV), tuberculosis (TB) continues to be a significant cause of death, accounting for over one-third of all deaths in this population. In Ethiopia, there is a lack of comprehensive and aggregated data on the national level for TB-associated mortality during co-infection with HIV. Therefore, this systematic review and meta-analysis aimed to estimate TB-associated mortality and identify risk factors for PLHIV in Ethiopia.MethodsWe conducted an extensive systematic review of the literature using the Preferred Reporting of Systematic Review and Meta-Analysis (PRISMA) guidelines. More than seven international electronic databases were used to extract 1,196 published articles from Scopus, PubMed, MEDLINE, Web of Science, HINARY, Google Scholar, African Journal Online, and manual searching. The pooled mortality proportion of active TB was estimated using a weighted inverse variance random-effects meta-regression using STATA version-17. The heterogeneity of the articles was evaluated using Cochran’s Q test and I2 statistic test. Subgroup analysis, sensitivity analysis, and Egger’s regression were conducted to investigate publication bias. This systematic review is registered in Prospero with specific No. CRD42024509131.ResultsOverall, 22 individual studies were included in the final meta-analysis reports. During the review, a total of 9,856 cases of TB and HIV co-infection were screened and 1,296 deaths were reported. In the final meta-analysis, the pooled TB-associated mortality for PLHIV in Ethiopia was found to be 16.2% (95% CI: 13.0–19.2, I2 = 92.9%, p = 0.001). The subgroup analysis revealed that the Amhara region had a higher proportion of TB-associated mortality, which was reported to be 21.1% (95% CI: 18.1–28.0, I2 = 84.4%, p = 0.001), compared to studies conducted in Harari and Addis Ababa regions, which had the proportions of 10% (95% CI: 6–13.1%, I2 = 83.38%, p = 0.001) and 8% (95% CI: 1.1–15, I2 = 87.6%, p = 0.001), respectively. During the random-effects meta-regression, factors associated with co-infection of mortality in TB and HIV were identified, including WHO clinical stages III & IV (OR = 3.01, 95% CI: 1.9–4.7), missed co-trimoxazole preventive therapy (CPT) (OR = 1.89, 95% CI: 1.05–3.4), and missed isoniazid preventive therapy (IPT) (OR = 1.8, 95% CI: 1.46–2.3).ConclusionIn Ethiopia, the mortality rate among individuals co-infected with TB/HIV is notably high, with nearly one-fifth (16%) of individuals succumbing during co-infection; this rate is considered to be higher compared to other African countries. Risk factors for death during co-infection were identified; the included studies examined advanced WHO clinical stages IV and III, hemoglobin levels (≤10 mg/dL), missed isoniazid preventive therapy (IPT), and missed cotrimoxazole preventive therapy (CPT) as predictors. To reduce premature deaths, healthcare providers must prioritize active TB screening, ensure timely diagnosis, and provide nutritional counseling in each consecutive visit.Systematic review registrationTrial registration number in Prospero =CRD42024509131 https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=509131.

China Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Female data was reported at 14.100 NA in 2016. This records a decrease from the previous number of 14.400 NA for 2015. China Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Female data is updated yearly, averaging 15.100 NA from Dec 2000 (Median) to 2016, with 5 observations. The data reached an all-time high of 18.100 NA in 2000 and a record low of 14.100 NA in 2016. China Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Female data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s China – Table CN.World Bank.WDI: Health Statistics. Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).; ; World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).; Weighted average;

The indicator measures the standardised death rate of tuberculosis, HIV and hepatitis (International Classification of Diseases (ICD) codes A15-A19_B90, B15-B19_B942 and B20-B24). The rate is calculated by dividing the number of people dying due to selected communicable diseases by the total population. Data on causes of death (COD) refer to the underlying cause which - according to the World Health Organisation (WHO) - is "the disease or injury which initiated the train of morbid events leading directly to death, or the circumstances of the accident or violence which produced the fatal injury". COD data are derived from death certificates. The medical certification of death is an obligation in all Member States. The data are presented as standardised death rates, meaning they are adjusted to a standard age distribution in order to measure death rates independently of different age structures of populations. This approach improves comparability over time and between countries. The standardised death rates used here are calculated on the basis of the standard European population referring to the residents of the countries.

United States US: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Male data was reported at 17.500 NA in 2016. This records an increase from the previous number of 17.200 NA for 2015. United States US: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Male data is updated yearly, averaging 17.500 NA from Dec 2000 (Median) to 2016, with 5 observations. The data reached an all-time high of 21.600 NA in 2000 and a record low of 17.200 NA in 2015. United States US: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Male data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s United States – Table US.World Bank.WDI: Health Statistics. Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).; ; World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).; Weighted average;